• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Direct Effect of Estrogen on Cultured Osteoclast Derived from Umbilical Cord Blood Mononuclear Cell

Research Project

Project/Area Number 12671573
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionHOKKAIDO UNIVERSITY

Principal Investigator

FURUTA Itsuko  Hokkaido Univ., Grad. School of Med., Assist. Prof., 大学院・医学研究科, 助手 (70238682)

Co-Investigator(Kenkyū-buntansha) FUJIMOTO Seiichiro  Hokkaido Univ., Grad. School of Med., Prof., 大学院・医学研究科, 教授 (60001898)
MINAKAMI Hisanori  Hokkaido Univ., Grad. School of Med., Prof., 大学院・医学研究科, 教授 (40102256)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2001: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2000: ¥2,300,000 (Direct Cost: ¥2,300,000)
KeywordsOSTEOCLAST / UMBILICAL CORD BLOOD / BONE RESORPTION / ESTROGEN
Research Abstract

Optimal culture condition was assessed in inducing osteoclast from the human umbilical cord mononuclear cells (uMNC). The uMNC were cultured in three DMEM/F12 medium containing 10% fetal bovine serum (FBS), 20% horse serum (HS) or 2% BSA(BSA), with or without following substances ; M-CSF, IL-4, osteoclast differentiation factor, and 1 α, 25-dihydroxyvitamine D3 (VD). Multinucleated cells positive for tartrate-resistant acid phosphatase were efficiently induced in uMNC cultured with M-GSF added FBS or M-CSF added BSA in the presence of VD, or with M-CSF added HS in the presence of IL-4. Calcitonin-induced cAMP production was significantly increased in uMNC cultured with M-CSF added HS in the presence of VD or M-CSF added BSA in the presence of IL-4. Bone resorbing activity was increased in uMNC cultured with M-CSF added HS in the presence of VD. Estradiol (E2) did not stimulate cAMP production of in uMNC cultured with BSA containing M-CSF and IL-4. LPS-induced TNFα production was investigated in 3 uMNC with estrogen receptor gene polymorphism PP, Pp, and pp cultured with BSA containing M-CSF and IL-4 in the precence (+) or absence of E2 (-). The LPS-induced TNFα production ratio of E2 (+) uMNC- to - E2 (-) uMNC was 0.60±0.06 for uMNC with PP, 1.06±0.06 for uMNCwith Pp, and 1.44±0.12 for uMNC with pp. Thus, both the estrogen and its receptor gene polymorphism affected the LPS-induced TNFα production in UMNC.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] 小林範子: "エストロゲンレセプター遺伝子多型がホルモン補充療法の骨密度に対する治療効果に与える影響について"Osteoporosis Japan. 8(1). 77-79 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 白銀 透: "骨粗鬆症治療におけるビタミンKとエストロゲン併用療法の検討"Osteoporosis Japan. 8(1). 94-96 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 小林範子: "ホルモン補充療法とエチドロネート単独療法による治療効果の比較検討"Osteoporosis Japan. 9(2). 361-365 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kishida, T: "Persistent detection of alfa-fetoprotein in the vagina without overt preterm premature rupture of the membranes"Fetal Diagnosis and Therapy. 16(5). 259-264 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Kobayashi, N.: "Estrogen receptor polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen"Maturitas. 41(3). 193-201 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Yamada, T: "Proceedings of the 53rd Annual Congress of Japan Society of Obstetrics and Gynecology"Monduzzi Editore S.p.A.Bologna(Italy). 159-164 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Noriko Kobayashi et al.: "Influence of the estrogen receptor gene polymorphism on the treatment effect of HRT on bone mineral density."Osteoporosis Japan. 8(1). 77-79 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Toru Shirogane et al.: "The study for the treatment of osteoporosis with vitamin K combined estrogen therapy."Osteoporosis Japan. 8(1). 94-96 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Noriko Kobayashi et al.: "The comparative study for the osteoporosis treatment with HRT and etidoronate alone therapy."Osteoporosis Japan. 9(2). 361-365 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Taturo Kishida et al.: "Persistent detection of alfa-fetoprotein in the vagina without overt preterm premature rupture of the membranes."Fetal Diagnosis and Therapy. 16(5). 259-264 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Takahiro Yamada et al.: "Persistent detection of alfa-fetoprotein in the vagina without overt preterm premature rupture of the membranes: clinical and chemical characterizations."Monduzzi Editore S.p.A. Bologna (Italy),Proceedings of the 53rd Annual Congress of Japan Society of Obstetrics and Gynecology. 159-164 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Noriko Kobayashi et al.: "Estrogen receptor polymorphism as genetic marker for bone loss, vertebral fractures and susceptibility to estrogen."Maturitas. 41(3). 193-201 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 小林範子: "ホルモン補充療法とエチドロネート単独療法による治療効果の比較検討"Osteoporosis Japan. 9(2). 361-365 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kishida, T: "Persistent detection of alfa-fetoprotein in the vagina without overt preterm premature rupture of the membranes"Fetal Diagnosis and Therapy. 16(5). 259-264 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamada, T: "Proceedings of the 53rd Annual Congress of Japan Society of Obstetrics and Gynecology"Monduzzi Editore S.p.A. Bologna(Italy). 159-164 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 小林範子: "エストロゲンレセプター遺伝子多型がホルモン補充療法の骨密度に対する治療効果に与える影響について."Osteoporosis Japan. 8(1). 77-79 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] 白銀透: "骨粗鬆症治療におけるビタミンKとエストロゲン併用療法の検討."Osteoporosis Japan. 8(1). 94-96 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi